APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dasatinib Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dasatinib Tablets Market Outlook and Growth Opportunities 2026

29 December 2025190 pages

Choose your research edition.

Industry ResearchDasatinib Tablets Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Dasatinib Tablets Industry Growth and Trends Forecast to 203260 pages · $3,450 USDMarket StructureGlobal Dasatinib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dasatinib Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Dasatinib Tablets Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Dasatinib Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dasatinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dasatinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dasatinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dasatinib Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dasatinib Tablets market include Bristol-Myers Squibb Pharma EEIG and LUCIUS Pharma among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Dasatinib Tablets market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dasatinib Tablets and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dasatinib Tablets revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Dasatinib Tablets market.

Dasatinib Tablets Segment by Company

Bristol-Myers Squibb Pharma EEIG

LUCIUS Pharma

Dasatinib Tablets Segment by Type

50mg

200mg

300mg

400mg

Dasatinib Tablets Segment by Application

Hospital

Clinic

Others

Dasatinib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dasatinib Tablets status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Dasatinib Tablets key companies, revenue, market share, and recent developments.

3. To split the Dasatinib Tablets breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Dasatinib Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dasatinib Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Dasatinib Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dasatinib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dasatinib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dasatinib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dasatinib Tablets industry.

Chapter 3: Detailed analysis of Dasatinib Tablets company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Dasatinib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Dasatinib Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dasatinib Tablets Industry Trends Table 2. Dasatinib Tablets Industry Drivers Table 3. Dasatinib Tablets Industry Opportunities and Challenges Table 4. Dasatinib Tablets Industry Restraints Table 5. Global Dasatinib Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dasatinib Tablets Revenue Share by Company (2021-2026) Table 7. Global Dasatinib Tablets Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Dasatinib Tablets Key Company Manufacturing Base & Headquarters Table 9. Global Dasatinib Tablets Company, Product Type & Application Table 10. Global Dasatinib Tablets Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Dasatinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 50mg Table 15. Significant Companies of 200mg Table 16. Significant Companies of 300mg Table 17. Significant Companies of 400mg Table 18. Global Dasatinib Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Dasatinib Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Dasatinib Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Dasatinib Tablets Sales Value Share by Type (2021-2026) Table 22. Global Dasatinib Tablets Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Clinic Table 25. Significant Companies of Others Table 26. Global Dasatinib Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Dasatinib Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Dasatinib Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Dasatinib Tablets Sales Value Share by Application (2021-2026) Table 30. Global Dasatinib Tablets Sales Value Share by Application (2027-2032) Table 31. Global Dasatinib Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Dasatinib Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Dasatinib Tablets Sales Value Share by Region (2021-2026) Table 34. Global Dasatinib Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Dasatinib Tablets Sales Value Share by Region (2027-2032) Table 36. Global Dasatinib Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Dasatinib Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Dasatinib Tablets Sales Value Market Share by Country (2021-2026) Table 39. Global Dasatinib Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Dasatinib Tablets Sales Value Market Share by Country (2027-2032) Table 41. Bristol-Myers Squibb Pharma EEIG Company Information Table 42. Bristol-Myers Squibb Pharma EEIG Business Overview Table 43. Bristol-Myers Squibb Pharma EEIG Dasatinib Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Bristol-Myers Squibb Pharma EEIG Dasatinib Tablets Product Portfolio Table 45. Bristol-Myers Squibb Pharma EEIG Recent Development Table 46. LUCIUS Pharma Company Information Table 47. LUCIUS Pharma Business Overview Table 48. LUCIUS Pharma Dasatinib Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. LUCIUS Pharma Dasatinib Tablets Product Portfolio Table 50. LUCIUS Pharma Recent Development Table 51. Research Programs/Design for This Report Table 52. Authors List of This Report Table 53. Secondary Sources Table 54. Primary Sources List of Figures Figure 1. Dasatinib Tablets Product Image Figure 2. Global Dasatinib Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dasatinib Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Dasatinib Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 50mg Image Figure 8. 200mg Image Figure 9. 300mg Image Figure 10. 400mg Image Figure 11. Global Dasatinib Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Dasatinib Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Dasatinib Tablets Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Clinic Image Figure 16. Others Image Figure 17. Global Dasatinib Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Dasatinib Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Dasatinib Tablets Sales Value Share by Application (2021-2032) Figure 20. Global Dasatinib Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Dasatinib Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Dasatinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 23. North America Dasatinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Dasatinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Dasatinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Dasatinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Dasatinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Dasatinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 29. South America Dasatinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Dasatinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Dasatinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Dasatinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 200mg
  • 300mg
  • 400mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Bristol-Myers Squibb Pharma EEIG
  • LUCIUS Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dasatinib Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dasatinib Tablets Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Dasatinib Tablets Market Dynamics
  1. 2.1 Dasatinib Tablets Industry Trends
  2. 2.2 Dasatinib Tablets Industry Drivers
  3. 2.3 Dasatinib Tablets Industry Opportunities and Challenges
  4. 2.4 Dasatinib Tablets Industry Restraints
3 Dasatinib Tablets Market by Company
  1. 3.1 Global Dasatinib Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Dasatinib Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Dasatinib Tablets Company Ranking (2024-2026)
  4. 3.4 Global Dasatinib Tablets Company Manufacturing Base and Headquarters
  5. 3.5 Global Dasatinib Tablets Company Product Type and Application
  6. 3.6 Global Dasatinib Tablets Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Dasatinib Tablets Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Dasatinib Tablets Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Dasatinib Tablets Market by Type
  1. 4.1 Dasatinib Tablets Type Introduction
  2. 4.1.1 50mg
  3. 4.1.2 200mg
  4. 4.1.3 300mg
  5. 4.1.4 400mg
  6. 4.2 Global Dasatinib Tablets Sales Value by Type
  7. 4.2.1 Global Dasatinib Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Dasatinib Tablets Sales Value by Type (2021-2032)
  9. 4.2.3 Global Dasatinib Tablets Sales Value Share by Type (2021-2032)
5 Dasatinib Tablets Market by Application
  1. 5.1 Dasatinib Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Dasatinib Tablets Sales Value by Application
  6. 5.2.1 Global Dasatinib Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dasatinib Tablets Sales Value by Application (2021-2032)
  8. 5.2.3 Global Dasatinib Tablets Sales Value Share by Application (2021-2032)
6 Dasatinib Tablets Regional Value Analysis
  1. 6.1 Global Dasatinib Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dasatinib Tablets Sales Value by Region (2021-2032)
  3. 6.2.1 Global Dasatinib Tablets Sales Value by Region: 2021-2026
  4. 6.2.2 Global Dasatinib Tablets Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dasatinib Tablets Sales Value (2021-2032)
  7. 6.3.2 North America Dasatinib Tablets Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Dasatinib Tablets Sales Value (2021-2032)
  10. 6.4.2 Europe Dasatinib Tablets Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Dasatinib Tablets Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Dasatinib Tablets Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Dasatinib Tablets Sales Value (2021-2032)
  16. 6.6.2 South America Dasatinib Tablets Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Dasatinib Tablets Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Dasatinib Tablets Sales Value Share by Country, 2025 VS 2032
7 Dasatinib Tablets Country-level Value Analysis
  1. 7.1 Global Dasatinib Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dasatinib Tablets Sales Value by Country (2021-2032)
  3. 7.2.1 Global Dasatinib Tablets Sales Value by Country (2021-2026)
  4. 7.2.2 Global Dasatinib Tablets Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Dasatinib Tablets Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Dasatinib Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Dasatinib Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bristol-Myers Squibb Pharma EEIG
  2. 8.1.1 Bristol-Myers Squibb Pharma EEIG Company Information
  3. 8.1.2 Bristol-Myers Squibb Pharma EEIG Business Overview
  4. 8.1.3 Bristol-Myers Squibb Pharma EEIG Dasatinib Tablets Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bristol-Myers Squibb Pharma EEIG Dasatinib Tablets Product Portfolio
  6. 8.1.5 Bristol-Myers Squibb Pharma EEIG Recent Developments
  7. 8.2 LUCIUS Pharma
  8. 8.2.1 LUCIUS Pharma Company Information
  9. 8.2.2 LUCIUS Pharma Business Overview
  10. 8.2.3 LUCIUS Pharma Dasatinib Tablets Revenue and Gross Margin (2021-2026)
  11. 8.2.4 LUCIUS Pharma Dasatinib Tablets Product Portfolio
  12. 8.2.5 LUCIUS Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst